| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
4e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
9e-05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
9e-05 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |